# OLOPATADINE HYDROCHLORIDE
> **ANDA204723** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-12-05
## Drug
- **FDA Application Number:** ANDA204723
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLOPATADINE HYDROCHLORIDE
- **Generic name:** Olopatadine Hydrochloride
- **Active ingredients:** OLOPATADINE HYDROCHLORIDE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Discontinued
- **Sponsor:** SCIEGEN PHARMS
- **First approval:** 2017-12-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204723)
---
*AI Analytics · CC0 1.0*